Arjunolic acid ameliorates reactive oxygen species via inhibition of p47(phox)-serine phosphorylation and mitochondrial dysfunction

Int J Biochem Cell Biol. 2015 Nov:68:70-7. doi: 10.1016/j.biocel.2015.08.015. Epub 2015 Aug 28.

Abstract

Impaired cardiovascular function during acute myocardial infarction (MI) is partly associated with recruitment of activated polymorphonuclear neutrophils. The protective role of arjunolic acid (AA; 2,3,23-trihydroxy olean-12-en-28-oic acid) is studied in the modulation of neutrophil functions in vitro by measuring the reactive oxygen species (ROS) generation. Neutrophils were isolated from normal and acute MI mice to find out the efficacy of AA in reducing oxidative stress. Stimulation of neutrophils with phorbol-12-myristate-13-acetate (PMA) resulted in an oxidative burst of superoxide anion (O2(-)) and enhanced release of lysosomal enzymes. The treatment of neutrophils with PMA induced phosphorylation of Ser345 on p47(phox), a cytosolic component of NADPH oxidase. Furthermore, we observed activated ERK induced phosphorylation of Ser345 in MI neutrophils. Treatment with AA significantly inhibited the phosphorylation of P47(phox) and ERK in the stimulated controls and MI neutrophils. Oxidative phosphorylation activities in MI cells were lower than in control, while the glycolysis rates were elevated in MI cells compared to the control. In addition, we observed AA decreased intracellular oxidative stress and reduced the levels of O2(-) in neutrophils. This study therefore identifies targets for AA in activated neutrophils mediated by the MAPK pathway on p47(phox) involved in ROS generation.

Keywords: Arjunolic acid; Extracellular regulated kinase; NADPH oxidase; Neutrophils; Reactive oxygen species.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Disease Models, Animal
  • Gene Expression Regulation
  • Glycolysis / drug effects
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / enzymology
  • Male
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Myocardial Infarction / genetics
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / pathology
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / genetics*
  • NADPH Oxidases / metabolism
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Neutrophils / pathology
  • Oxidative Phosphorylation / drug effects
  • Oxidative Stress / drug effects
  • Phosphorylation / drug effects
  • Primary Cell Culture
  • Signal Transduction
  • Superoxides / antagonists & inhibitors
  • Superoxides / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • Triterpenes / pharmacology*

Substances

  • Antioxidants
  • Triterpenes
  • Superoxides
  • arjunolic acid
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Mapk1 protein, mouse
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Tetradecanoylphorbol Acetate